Latest Breaking News On - I astellas pharma inc - Page 1 : comparemela.com

European Commission Approves PADCEV™ (enfortumab vedotin) for Locally Advanced or Metastatic Urothelial Cancer

United statesKenji yasukawaAhsan arozullahEnfortumab vedotinUniversitario marquEuropean commission approvesAmerican society of clinical oncologyEuropean commissionAstellas pharma us incSeagen incI astellas pharma incAstellas pharma incEuropean union eu member statesEuropean unionEuropean medicines agencyLocally advanced